The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period
Clinical trial NCT00892970 · COMPLETED
Trial details
- NCT number
- NCT00892970
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-01-01
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.